Clinical trial
Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis
NCT04749667
Study timeline
Study start (actual)2021-08-09Date precision: day
Registry last updated2026-03-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosisunresolved
Progressive Multiple Sclerosisunresolved
Interventions
Sponsors & collaborators
Haukeland University Hospitallead sponsor
University of Bergencollaborator
University Hospital Ulmcollaborator
University Hospital, Akershuscollaborator
University Hospital of North Norwaycollaborator
St. Olavs Hospitalcollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04749667 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.